RESEARCHER PROFILE
Demetres D. Leonidas
← Back to University of Thessaly
D
University of Thessaly
Demetres D. Leonidas works in Enzyme Structure and Function, Glycogen Storage Diseases and Myoclonus, Carbohydrate Chemistry and Synthesis, Biochemical and Molecular Research, Protein Structure and Dynamics. Recorded institutional associations include University of Thessaly.
285Publications
4,178Citations
36H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Naturally Occurring Pentacyclic Triterpenes as Inhibitors of Glycogen Phosphorylase: Synthesis, Structure−Activity Relationships, and X-ray Crystallographic Studies
2008 · 191 citationsStructural Basis for the Recognition of Carbohydrates by Human Galectin-7,
1998 · 190 citationsCrystal structure of human Charcot–Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins
1995 · 154 citationsNew Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents
2008 · 143 citationsCharcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion
2002 · 121 citationsDesign of Inhibitors of Glycogen Phosphorylase: A Study of .alpha.- and .beta.-C-Glucosides and 1-Thio-.beta.-D-glucose Compounds
1994 · 119 citationsAnopheles gambiae odorant binding protein crystal complex with the synthetic repellent DEET: implications for structure-based design of novel mosquito repellents
2011 · 114 citationsSelective Recognition of Mannose by the Human Eosinophil Charcot-Leyden Crystal Protein (Galectin-10): A Crystallographic Study at 1.8 Å Resolution,
1999 · 110 citationsThe Crystal Structure of Human Placenta Growth Factor-1 (PlGF-1), an Angiogenic Protein, at 2.0 Å Resolution
2001 · 110 citationsNicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
2020 · 97 citationsRefined Crystal Structures of Native Human Angiogenin and Two Active Site Variants: Implications for the Unique Functional Properties of an Enzyme Involved in Neovascularisation During Tumour Growth
1999 · 90 citationsKinetic and crystallographic studies on 2‐(β‐D‐glucopyranosyl)‐5‐methyl‐1, 3, 4‐oxadiazole, ‐benzothiazole, and ‐benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site
2005 · 89 citationsCrystal Structures of Ribonuclease A Complexes with 5‘-Diphosphoadenosine 3‘-Phosphate and 5‘-Diphosphoadenosine 2‘-Phosphate at 1.7 Å Resolution,
1997 · 80 citationsThe structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor
1997 · 77 citationsNatural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
2014 · 73 citationsAmide-1,2,3-triazole bioisosterism: the glycogen phosphorylase case
2009 · 72 citationsBinding of N‐acetyl‐N ′‐β‐ d ‐glucopyranosyl urea and N‐benzoyl‐N ′‐β‐ d ‐glucopyranosyl urea to glycogen phosphorylase b
2002 · 69 citationsCrystal Structure of Eosinophil Cationic Protein at 2.4 Å Resolution,
1999 · 66 citationsIminosugars as Potential Inhibitors of Glycogenolysis: Structural Insights into the Molecular Basis of Glycogen Phosphorylase Inhibition
2006 · 65 citationsGlucose-based spiro-isoxazolines: A new family of potent glycogen phosphorylase inhibitors
2009 · 62 citationsNicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
2020 · 62 citationsHigh‐resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure‐based design of ribonucleolytic inhibitors
2003 · 56 citationsCrystal Structure of the Eosinophil Major Basic Protein at 1.8 Å
2001 · 53 citationsMapping the Ribonucleolytic Active Site of Eosinophil-derived Neurotoxin (EDN)
2001 · 47 citationsToward Rational Design of Ribonuclease Inhibitors: High-Resolution Crystal Structure of a Ribonuclease A Complex with a Potent 3‘,5‘-Pyrophosphate-Linked Dinucleotide Inhibitor,
1999 · 46 citations
